Kalvista Pharmaceuticals Inc (KALV) — Cash Flow-to-Debt Ratio
Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow-to-Debt Ratio of -0.10x as of October 2025, meaning its operating cash flow of $-32.68 Million could theoretically repay 0% of its total liabilities ($322.93 Million) in one year. Check Kalvista Pharmaceuticals Inc (KALV) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kalvista Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Kalvista Pharmaceuticals Inc across 16 annual periods. Also explore Kalvista Pharmaceuticals Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kalvista Pharmaceuticals Inc (2013–2025)
Year-by-year debt coverage analysis for Kalvista Pharmaceuticals Inc. For market capitalisation and broader financial context, see how much is Kalvista Pharmaceuticals Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.98x | $-152.91 Million | $155.38 Million | ▲ +68.2% |
| 2024 | -3.10x | $-89.23 Million | $28.82 Million | ▲ +8.8% |
| 2023 | -3.39x | $-75.26 Million | $22.18 Million | ▲ +18.4% |
| 2022 | -4.16x | $-78.13 Million | $18.79 Million | ▼ -104.3% |
| 2021 | -2.04x | $-30.17 Million | $14.82 Million | ▲ +60.1% |
| 2020 | -5.11x | $-44.82 Million | $8.78 Million | ▼ -200.4% |
| 2019 | -1.70x | $-36.37 Million | $21.39 Million | ▼ -649.6% |
| 2018 | 0.31x | $10.56 Million | $34.14 Million | ▲ +103.9% |
| 2017 | -7.86x | $-23.72 Million | $3.02 Million | ▼ -94.1% |
| 2016 | -4.05x | $-13.16 Million | $3.25 Million | ▼ -426.0% |
| 2016 | -0.77x | $-5.08 Million | $6.60 Million | ▲ +72.4% |
| 2015 | -2.79x | $-20.86 Million | $7.48 Million | ▼ -2125.8% |
| 2015 | -0.13x | $-6.37 Million | $50.83 Million | ▲ +87.5% |
| 2014 | -1.00x | $-11.25 Million | $11.27 Million | ▼ -800.6% |
| 2014 | -0.11x | $-4.86 Million | $43.81 Million | ▼ -122.4% |
| 2013 | -0.05x | $-1.83 Million | $36.81 Million | — |